Las Vegas, NV · Founded 2015 · Privately Held (backing)
Developer of a medicinal drug designed to prevent disease and heal patients afflicted with illness through genomics. Heligenics is based in Las Vegas, NV and was founded in 2015. Its last reported valuation was $17.2 million in Aug 2022. It has raised $6 million across 3 recorded rounds; the latest was a $2.6 million seed round in Aug 2024.
Last reported valuation
$17.2M
Oct 2026
Priced at
—
Total raised
$6.0M
Last round
Seed Round
Aug 2024
Team — not yet on record
No current team members for Heligenics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Heligenics with a free account
·Watch Heligenics: the Monday email on marks, rounds and moves
